Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance

NCT04771884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-04-13

No results posted yet for this study

Summary

The investigator's purpose is to study the population pharmacokinetics of commonly used antimicrobial agents in children of bacterial meningitis with augmented renal clearance and assess dosage individualization feasibility.

Conditions

  • Bacterial Meningitis
  • Augmented Renal Clearance

Interventions

DRUG

meropenem vancomycin ceftazidime ceftriaxone ceftizoxime linezolid

The use of antimicrobial agents depends on the clinical practice

Sponsors & Collaborators

  • Children's Hospital of Chongqing Medical University

    collaborator OTHER
  • Shandong University

    lead OTHER

Eligibility

Min Age
2 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2026-01-20
Completion
2026-03-20
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771884 on ClinicalTrials.gov